These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1649037)

  • 1. Mechanisms in TGF-beta action.
    Massagué J; Heino J; Laiho M
    Ciba Found Symp; 1991; 157():51-9; discussion 59-65. PubMed ID: 1649037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell adhesion to collagen and decreased myogenic gene expression implicated in the control of myogenesis by transforming growth factor beta.
    Heino J; Massagué J
    J Biol Chem; 1990 Jun; 265(18):10181-4. PubMed ID: 2162338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities.
    Chen RH; Ebner R; Derynck R
    Science; 1993 May; 260(5112):1335-8. PubMed ID: 8388126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta.
    Massagué J; Cheifetz S; Laiho M; Ralph DA; Weis FM; Zentella A
    Cancer Surv; 1992; 12():81-103. PubMed ID: 1638549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-beta receptor.
    Filvaroff EH; Ebner R; Derynck R
    Development; 1994 May; 120(5):1085-95. PubMed ID: 8026322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
    Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
    Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of transforming growth factor beta 1 resistance by the E1A oncogene requires binding to a specific set of cellular proteins.
    Missero C; Filvaroff E; Dotto GP
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3489-93. PubMed ID: 1673033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF beta regulation of epithelial cell proliferation: role of tumor suppressor genes.
    Moses HL; Pietenpol JA; Münger K; Murphy CS; Yang EY
    Princess Takamatsu Symp; 1991; 22():183-95. PubMed ID: 1844240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of epithelial proliferation by TGF-beta.
    Moses HL; Yang EY; Pietenpol JA
    Ciba Found Symp; 1991; 157():66-74; discussion 75-80. PubMed ID: 2070684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction.
    Laiho M; Weis MB; Massagué J
    J Biol Chem; 1990 Oct; 265(30):18518-24. PubMed ID: 2170414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between actions of transforming growth factor (TGF)-beta and cell surface expression of its receptors in clonal osteoblastic cells.
    Takeuchi Y; Fukumoto S; Matsumoto T
    J Cell Physiol; 1995 Mar; 162(3):315-21. PubMed ID: 7860639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation.
    Hyytiäinen M; Penttinen C; Keski-Oja J
    Crit Rev Clin Lab Sci; 2004; 41(3):233-64. PubMed ID: 15307633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of murine cranial suture patency mediated by a dominant negative transforming growth factor-beta receptor adenovirus.
    Song HM; Fong KD; Nacamuli RP; Warren SM; Fang TD; Mathy JA; Cowan CM; Aalami OO; Longaker MT
    Plast Reconstr Surg; 2004 May; 113(6):1685-97. PubMed ID: 15114130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: receptor and postreceptor signaling.
    Ito M; Yasui W; Kyo E; Yokozaki H; Nakayama H; Ito H; Tahara E
    Cancer Res; 1992 Jan; 52(2):295-300. PubMed ID: 1309437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation.
    Laiho M; DeCaprio JA; Ludlow JW; Livingston DM; Massagué J
    Cell; 1990 Jul; 62(1):175-85. PubMed ID: 2163767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation.
    Verrecchia F; Mauviel A
    J Invest Dermatol; 2002 Feb; 118(2):211-5. PubMed ID: 11841535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responsiveness to transforming growth factor-beta (TGF-beta) restored by genetic complementation between cells defective in TGF-beta receptors I and II.
    Laiho M; Weis FM; Boyd FT; Ignotz RA; Massagué J
    J Biol Chem; 1991 May; 266(14):9108-12. PubMed ID: 1851167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability.
    Zhu S; Goldschmidt-Clermont PJ; Dong C
    Circ Res; 2004 Mar; 94(5):617-25. PubMed ID: 14739161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cis-4-Hydroxy-L-proline and ethyl-3,4-dihydroxybenzoate prevent myogenesis of C2C12 muscle cells and block MyoD1 and myogenin expression.
    Saitoh O; Periasamy M; Kan M; Matsuda R
    Exp Cell Res; 1992 May; 200(1):70-6. PubMed ID: 1373388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta's delay skeletal muscle progenitor cell differentiation in an isoform-independent manner.
    Schabort EJ; van der Merwe M; Loos B; Moore FP; Niesler CU
    Exp Cell Res; 2009 Feb; 315(3):373-84. PubMed ID: 19038250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.